Achievement in Malaria Vaccine Trials in Africa

Johannesburg: New research shown that an anti-malaria vaccine offering developed protection to children could be registered for use in four years, saving millions of young lives.  

Panel: Children Under Age 6 Shouldn’t Be Given Cold Drugs

U.S. panel said that children under age 6 should not get non-prescribed cold medicines including Johnson & Johnson’s PediaCare and Wyeth’s Dimetapp.  

Experts Warn Against Injections Promoting Fertility

Mothers and babies are put on risk by the fertility-growth injections given to thousands of British women every year, may be a waste of time and money, said experts.

POSCO To Start Work On Orrisa Steel Plant By April Next Year

Posco, Ku-Taek Leethe world’snavin-patnaik

Ambuja Cements Falls On Open Offer Delay

AmbujaCementMumbai: Ambuja Cements Ltd has turned down 3.86 per cent to Rs 139.60 after Swis

Indian Users Want More In Low-Priced Mobile Phones - IDC Study Report

Bangalore: IDCIndian users have complained that entry-level mobile handsets are not fun enough.

Pages

News in Focus

Tata Consultancy Services (TCS) Share Price Target at Rs 3,900: Sharekhan Research

In its latest research update, Mirae Asset Sharekhan maintains a BUY recommendation on Tata Consultancy Services (TCS), India’s IT bellwether, despite a challenging quarter marked by subdued revenu

Glenmark Pharmaceuticals Share Price Target at Rs 2,430: Motilal Oswal Research

Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Exness Registrations Ban on Indian Users; Detailed Review and Implication of Forex Trading on Non-FIU Complaint Platforms

Exness has stopped new memberships in India and there isn't any clarification from the company regarding this change.

How Typography Enhances Readability and Visual Appeal in Posters

Typography is one of the most crucial elements of poster design.

SBI Life Share Price Jumps 1.37 Percent; Immediate Resistance at Rs 1,862

SBI Life Share price jumped 1.37 percent on Friday and the stock is currently looking bullish on technical charts. We could face minor resistance in range of Rs 1,860 - 1,875.

Crompton Greaves Consumer Share Price Target at Rs 410: Kotak Securities

Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.